MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection.
about
Patients infected with CRF07_BC have significantly lower viral loads than patients with HIV-1 subtype B: mechanism and impact on disease progressionCoreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotypeDefining the fitness of HIV-1 isolates with dual/mixed co-receptor usageHIV-1 with multiple CCR5/CXCR4 chimeric receptor use is predictive of immunological failure in infected children.Mode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid isolates.Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patientsFrequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease--indication of an evolving epidemic in West AfricaHuman immunodeficiency virus (HIV)-positive sera obtained shortly after seroconversion neutralize autologous HIV type 1 isolates on primary macrophages but not on lymphocytes.HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entry.Antigenic variation within the CD4 binding site of human immunodeficiency virus type 1 gp120: effects on chemokine receptor utilization.Antiretroviral therapy in the clinicDifferential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue.Increased sensitivity to broadly neutralizing antibodies of end-stage disease R5 HIV-1 correlates with evolution in Env glycosylation and charge.Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesisDistinct molecular pathways to X4 tropism for a V3-truncated human immunodeficiency virus type 1 lead to differential coreceptor interactions and sensitivity to a CXCR4 antagonist.Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure.Human immature Langerhans cells restrict CXCR4-using HIV-1 transmission.HIV-1 utilizes the CXCR4 chemokine receptor to infect multipotent hematopoietic stem and progenitor cells.The presence of CXCR4-using HIV-1 prior to start of antiretroviral therapy is an independent predictor of delayed viral suppressionSelective transmission of R5 HIV-1 variants: where is the gatekeeper?Alterations in HIV-1 gp120 V3 region are necessary but not sufficient for coreceptor switching in CRF07_BC in China.Recombination-mediated changes in coreceptor usage confer an augmented pathogenic phenotype in a nonhuman primate model of HIV-1-induced AIDS.Rapid evolution of human immunodeficiency virus strains with increased replicative capacity during the seronegative window of primary infection.Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes.The cytopathicity of a simian immunodeficiency virus Mne variant is determined by mutations in Gag and Env.CD4-independent use of the CCR5 receptor by sequential primary SIVsm isolatesDual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression.The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells.Exceptional molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype C infection.Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIVSF162P3N molecular clones in rhesus macaques.CD133+ hematopoietic progenitor cells harbor HIV genomes in a subset of optimally treated people with long-term viral suppression.Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates.Derivation and characterization of a simian immunodeficiency virus SIVmac239 variant with tropism for CXCR4.Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectively.High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatmentDeterminant in human immunodeficiency virus type 1 for efficient replication under cytokine-induced CD4(+) T-helper 1 (Th1)- and Th2-type conditions.The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus.On the Physicochemical and Structural Modifications Associated with HIV-1 Subtype B Tropism Transition.Length polymorphism within the second variable region of the human immunodeficiency virus type 1 envelope glycoprotein affects accessibility of the receptor binding site.Contrasting use of CCR5 structural determinants by R5 and R5X4 variants within a human immunodeficiency virus type 1 primary isolate quasispecies.
P2860
Q28542678-3B27EC95-2D70-4CE7-80AD-37B845A08008Q28646874-CDD6E2DD-A8CD-4AD8-A23A-50B59A9E81F1Q30278577-BCD77B71-983C-490B-8F02-821CBEDB6466Q33372329-BDEE3852-2E53-421D-9D66-5E83DE480B48Q33686847-4864F457-7069-495F-942F-18CCAC488C8BQ33785357-C68DD62E-F831-4163-9FF4-B542D8D8534EQ33793066-C3D5D538-7E2E-4C58-96D7-F41451906A53Q33805324-BE708C7F-4D34-405E-B10C-3E4B8125FA38Q33807529-47F94818-1DD6-46ED-BAC6-A0A8AD328BB8Q33841969-27BE6836-49D5-4ACE-86DC-013F56AD5ED4Q33877347-BD3FD037-5D5E-4646-AD0C-465D46368BBCQ33930335-DC6936AC-19E7-4483-B27A-D06FF1067E2AQ33941033-1FECA9ED-441C-48AE-978A-01FE9BDA9304Q34010283-88121784-0368-46F1-9AA8-46A6F05FE10DQ34055508-3EBBD3C0-0F20-4F4A-94FB-D93B695AE013Q34342200-E178699D-6191-4B4E-8F54-091BED64AF1DQ34486236-4B8A4BAA-E53C-4B86-9476-CB7A0CE4653DQ35007831-0E5568DD-CD05-4E76-B8F4-57D852CDEAA0Q35009308-C693EDFE-1489-4658-B822-B868312FB6C8Q35018140-C754AFB8-AEDE-4541-A334-9FCEA3E3B42BQ35133895-73E451B3-ABBA-4B8F-B3F1-927797E3892FQ35274968-11A7E9B5-2FAB-4D9F-B450-FDA180CDA79AQ35871314-0D42354B-F10E-47D2-852F-09EA03606822Q35874433-8A50CFE9-5CB0-4375-BEC6-2C082876B7B5Q35895738-909FC270-E03D-42B5-B981-8FC160AFB6EDQ35946467-07268BF4-261F-4238-823D-D2A6367A39B6Q36225692-625EC792-AFAE-4CE3-BEA3-21E48378D23BQ36264736-4F62CD00-0C1B-46D4-921C-85A75BFE355FQ36539298-672D022E-4DC1-4518-BB8D-207E5AFBE078Q36608554-DECDBD09-59A7-4A0C-B69F-43E62710D8E6Q36846285-EF23D7FF-96E5-411F-A6FC-3686275B9F85Q37094738-FE4372C8-981C-488A-8921-283F5FC1F355Q37356010-5582289C-888A-46AA-807D-760D5B40C8EDQ37374348-5E2B9D05-0729-4A6B-8EB1-AE082C337DB0Q39109516-C30108E8-4813-4242-BB72-08BA1D068B1CQ39500940-702D1684-5637-4774-AC3B-20AA30E55E0EQ39579438-E65D2FCA-35A3-49EA-97B6-3D6047AABD2FQ39856422-663B9698-C5AA-4A03-839F-2B0B64F145EDQ39877884-BFC03071-3DA1-4302-8C4D-7B9E48DF3DF3Q40132975-1E151DB8-0506-4803-B220-10A074BF02BA
P2860
MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
MT-2 cell tropism as prognosti ...... ciency virus type 1 infection.
@en
type
label
MT-2 cell tropism as prognosti ...... ciency virus type 1 infection.
@en
prefLabel
MT-2 cell tropism as prognosti ...... ciency virus type 1 infection.
@en
P2093
P2860
P1476
MT-2 cell tropism as prognosti ...... ciency virus type 1 infection.
@en
P2093
P2860
P304
P407
P577
1994-02-01T00:00:00Z